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Severe restriction in jaw movement after routine injection of
local anesthetic in patients who have fibrodysplasia
ossificans progressiva
Wayne Luchetti, MD! Randolph B. Cohen, MD,a Gregory V. Hahn, MD,a
David M. Rocke, PhD,b Mark Helpin, DMD,c Michael Zasloff, MD, phD,d and
Frederick S. Kaplan, MD,e Philadelphia, Pa., and Davis, Calif.
UNIVERSITY OF PENNSYL V ANlA SCHOOLS OF MEDICINE AND DENTAL MEDICINE AND
UNIVERSITY OF CALIFORNIA, DAVIS
Objective. To determine the relationship of dental procedures to immediate ossification and arlkylosis of the jaw in
patients who have fibrodysplasia ossificans progressiva.
Study design. A mail survey was conducted of the 60 patient-members of the International Fibrodysplasia Ossificans
Progressiva Association. All 41 patients (18 males, 23 females) who responded were examined. Instantaneous exact
hazard rates for ossification of the jaw were calculated by the Weibull model.
Results. Thirty-six patients had dental procedures performed. Twenty-one (58%) patients had rE~eived an injection of
local anesthetic. Five (24%) patients had an immediate flare-up of fibrodysplasia ossificans progressiva with ossification
and permanent ankylosis of the jaw (expected occurrence, 0.031; P < 0.0001). None of the 12 patients who had
comparable dental work without injections developed heterotopic ossification (expected occurrence, 0.019; not
significant).
Conclusion. Injections of local anesthetic during dental procedures pose serious and immediate risk for inciting
heterotopic ossification and ankylosis of the jaw in patients who have fibrodysplasia ossificans progressiva and should be
assiduously avoided.
(ORAL SURG ORAl MED ORAL PATHOl ORAL RADIOl ENDOD 1996;81:21-5)
Fibrodysplasia ossificans progressiva (FOP) is an ex-
tremely rare! and disabling2 heritable disorder3 of
connective tissue characterized by progressive post-
natal heterotopic ossification of soft tissue4 and by
congenital malformation of the great toes.s There are
presently fewer than 80 known living patients in the
United States with the condition.3 Autosomal domi-
nant inheritance has been demonstrated,3 but most
cases arise by spontaneous mutation.6 The genetic
defect and the pathogenesis of bone fonnation in FOP
is unknown. The bone morphogenetic proteins have
been postulated as candidate genes on the basis of
their ability to induce heterotopic ossification and
their ability to regulate vertebrate pattern fonnation!
The first manifestation of impending ossification at
an anatomic site is the occurrence of wann, painful,
nodules in the soft connective tissues.8 These nodules
resemble aggressive fibromatosis3 but develop
through an endochondral pr<>cess to fonn mature het-
erotopic bone that is morphologically indistinguish-
able from mature normotopic bone.3 This heterotopic
bone bridges and rigidly imrnobilizes the joints of the
axial and appendicular skeleton, making movement
impossible.8 Heterotopic bone fonnation in FOP
progresses in specific anatomic and temporal patterns
beginning in cranial, proximal, axial, and dorsal
regions and later involving more caudal, distal,
appendicular, and ventral regions}
Disease exacerbation carl be stimulated by blunt
trauma or may occur spontaneously} Surgical re-
moval of heterotopic bone is futile, as tissue trauma
associated with surgery inevitably leads to the stim-
ulation of even more robust ossification at the surgi-
cal site.i.8 Furthermore, medical therapy has been
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Table I. Clinical data on 21 patients with FOP who received injections during dental procedures
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empiric because of the lack of knowledge of the
pathogenesis of FOP. At this time there is no effec-
tive treatment for the condition.
The temporomandibular joint (TMJ) is character-
istically one of the last joints to be affected with het-
erotopic ossification2 as the risk of jaw involvement
is very low for young children but increases with age.9
In a recent large review of patients, osseous bridging
across the TMJ occurred in 71 % of FOP patients by
a mean age of 18 years (standard deviation, 7 years;
range, 5 to 26 years) and led to permanent ankylosis
of the jaw.2 Patients have reported anecdotally that
various forms of dental treatment may have precipi-
tated heterotopic bone formation around the jaw re-
gardless of age. However, conclusions have been
based on small samples of patients without detailed
dental histories. The present study uses data from a
large sample of patients with FOP with detailed den-
tal histories, assesses the risk of various aspects of
dental therapy, and generates guidelines for the den-
tal care of these patients.
ings, extractions, or braces. The study was designed
to note the use of any injected local anesthetic as well
as the temporal relationship of injections to FOP
flares in the TMJ. In addition, all patients who
reported having injections of local anesthetic were
contacted by telephone to obtain a more detailed
dental history and an account of any heterotopic os-
sification of the TMJ. All 60 patients had been seen
and examined by one of the two senior investigators
(M.A.Z. or F.S.K.) between 1977 and 1993 and a di-
agnosis of FOP had been confirmed in all cases. At
the time the survey was conducted, the 60 patient-
members of the International FOP Association repre-
sented more than 90% of all knowr! patients in the
United States who had FOP.
A Weibull model was used to calculate instanta-
neous exact hazard rates for ossification of the jaw (a
joint with nonconstant hazard) based on the data of
Rocke et al.9
METHODS
A detailed dental health survey was mailed to the
60 patient-members of The International Fibrodys-
plasia Ossificans Progressiva Association. The sur-
vey was designed to ascertain each patient's age,
gender, age of onset of heterotopic ossification in the
jaw, as well as a history of dental care including fill-
RESULTS
The mail survey was returned by 41 patients (68%
response). There were 18 males and :2.3 females. The
age of the respondents ranged from 3 to 69 (mean age,
28) years. Twelve (67%) of the 18 males and 18
(78%) of the 23 females reported jaw restriction. The
mean age of onset of ossification in the jaw was 17
years.
Thirty-six (88%) of the 41 patients reported having
hood. All six had fixed appliances in place from 6
months to 1 ~ years in duration. This was followed in
three patients with the use of removable appliances.
All six patients denied having any FOP flares as a re-
sult of the application or removal of fixed appliances
or the routine use of removable appliances. One of the
patients reported having had tooth extractions to fa-
cilitate eating after rigid ankylosis of the jaw. The
procedure was performed with the patient under a
general anesthetic, and no disease flare-up was
reported.
DISCUSSION
The results of this surve:y establish that injections
of local anesthetic during dental procedures pose
substantial added risk for inciting heterotopic ossifi-
cation and subsequent ankylosis of the TMJ in
patients who have FOP. There was no significant
added risk of immediate heterotopic ossification of
the jaw after dental procedures in which there was no
injection of local anesthetic. Several biases may have
been introduced during this study. First, we relied on
the records and memories 'Df patients and their fam-
ilies rather than on clinician-generated dental records,
and therefore certain recall biases or errors may have
been introduced. Although many patients had metic-
ulously recorded in diaries the details of their dental
history and medical care, we were unable to deter-
mine whether the injectiollis occurred in the maxilla
or in the mandible or whetJ~er they were infiltrations
or nerve blocks. This was tile major flaw in the study.
Second, approximately one: third of the surveyed pa-
tients did not return the questionnaire, and we were
thus unable to obtain useful information with respect
to dental procedures from that group. However, care-
had a dental procedure (fillings or extractions) per-
formed. Twenty-one (54%) of the 36 patients who had
dental work performed had received an injection of a
local anesthetic during the procedure (Table I),
whereas 12 of the 26 patients who had comparable
dental procedures did not receive an injection of a lo-
cal anesthetic (Table II). Detailed telephone fol-
low-up of the 21 patients who received injections re-
vealed that five (24%) patients reported an immedi-
ate FOP flare (defined as marked swelling and
stiffening leading to permanent loss of jaw motion)
within several days of an injection (expected occur-
rences, 0.031; p < 0.0001). The null hypothesis that
the observed ossification events had no relationship
to the injection that preceded it was thus rejected at
ap value of <0.0001. None of the 12 patients who had
fillings or extractions performed without injections
had developed heterotopic ossification as a result of
the procedure (expected occurrences, 0.019; not sig-
nificant). One patient (patient 12, Table I) reported
marked stiffening of her jaw after an injection, but the
stiffening resolved in 1 week. Three (14%) of the 21
reported that some form of local trauma to the neck
or jaw (a fall, a clothesline injury, and a bicycle ac-
cident) led directly to an FOP flare in the TMJ. In ad-
dition, another patient (patient 17, Table I) reported
having surgery to remove the heterotopic bone in the
jaw, but the surgery led to a marked worsening of the
condition and resulted in further heterotopic ossifica-
tion with resultant ankylosis of the jaw. The flare-up
and subsequent ankylosis in this case was attributed
to the overwhelming trauma of surgery rather than to
any injection.
Six (29%) of the 21 patients contacted by phone
reported having orthodontic appliances during child-
24 Luchett! et al. ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY
January 1996
41
Patients
#../""""",,~
5 36
No DentaI Work DentaI Work
3~ J-"~
No Response 21
about Injections Received Injection
12
:T:
0 12
FOP Rare No FOP Flare
Expected inslananeous n_-ups, 0.019
Actual n_-ulII. 0
(p is not significant)
5 16
FOP Flare No FOP Flare
Expected instananeous flare-u~ 0.031
Actual flare-ups. 5
(p < 0.<XXJ1)
Fig. 1. Schematic diagram illustrates composition of study group according to occurrence of dental pro-
cedure, administration of injection, and occurrence of FOP flare.
ful review of old records in our possession on all of
these patients failed to reveal any substantial differ-
ences between them and those who completed the
survey.
Renton et allo described the unusual roentgeno-
graphic appearance of the TMJs in two patients who
had FOP and suggested that this unusual appearance
was a characteristic feature of the underlying skeletal
dysplasia in patients who had the disorder. Jonathan
and Jefferis II presented an isolated case report of an
18-year-old girl who had an acute submandibular
swelling as the presenting sign of FOP. Although
several of our patients had experienced spontaneous
submandibular swelling and subsequent ossification,
none specifically reported it after a dental procedure
or after an injection of a local anesthetic.
Several reports have noted that dental therapy may
accelerate the natural course of heterotopic ossifica-
tion in the jaw,2. 12 as occurred in our patient 17 (Ta-
ble I). In their 1982 study, Connor et al.1 suggested,
"Dental therapy should be cautious" in these pa-
tients, but no specific recommendations were made.
Our study shows that as many as 24% of the patients
with FOP who had received an injection of a local
anesthetic as part of a dental procedure developed
heterotopic ossification around the jaw within a week
of the injection. In those patients who reported no jaw
restriction, 55% underwent extractions or fillings
without injections. At present, it is not possible to de-
tem1ine if the trauma of injection, the local anesthetic
agent itself, or a combination of both incited the local
ossification process. However, considering the sensi-
tivity of FOP to trauma, it is likely that the trauma of
the injections rather than the specific agent injected
led to stimulation of heterotopic ossification in the
jaws of patients who have FOP.
In general, subcutaneous and intravenous injec-
tions are not problematic in patients who have FOP,
whereas deep intramuscular injections of any type are
more likely to cause a flare-up. I Therefore we
strongly recommend the avoidance of any intramus-
cular or buccal injections during dental work in pa-
tients who have FOP. We also recommend that assid-
uous attention be directed to the prevention of dental
caries, as prevention would decrease the need for in-
vasive dental procedures. Preventative measures
should include early, regular, and periodic dental vis-
its, oral hygiene instruction, nubitional counseling,
fluoride suppiementation,I3 home fluorides,I4 and
dental sealants.IS
Only one patient in our survey (patient 17, Table I)
had surgery to remove the heterotopic bone in his jaw,
and the surgery led rapidly to a worsening of his con-
dition. This is consistent with ~:veral previous re-
ports.8. 12 Rogers and Geho8 reported 55 operations or
biopsies in 37 patients with FOP and found that 34
patients experienced an exacerbation of the condition
after a surgical procedure. In another study, Crofford
~Y
96
et al.12 combined surgery with isotretinoin treatment
(a drug with known inhibitory effects on differentia-
tion of mesenchymal tissue) in an attempt to remove
osseous bridges across the TMJ of two patients. Both
patients, however, had clinical and roentgenographic
evidence of recurrence of heterotopic ossification
across the joint within 2 months after surgery. Thus,
we strongly recommend avoidance of any surgical
procedures to remove heterotopic bone in the jaw in
patients who have FOP. 1. 4
Six of the 21 patients from whom we obtained de-
tailed dental histories had used orthodontic appli-
ances, and none of the six patients reported FOP
flare-ups as a result of that therapy. We suggest that
orthodontic care need not be avoided in these patients,
but we do suggest avoidance of stretching of the jaw
during the application or removal of braces or during
any other dental procedure.
Our study shows that in patients with FOP, routine
injections of local anesthetic for dental procedures
may exacerbate the formation of heterotopic bone
about the jaw and lead to permanent loss of TMJ
movement. When dental procedures are necessary,
the injection of a local anesthetic should be avoided
whenever possible. If unavoidable, injections should
be as atraumatic as possible, should be limited to
subcutaneous infiltration, and should assiduously
avoid intramuscular penetration. Vigilant attention
should be directed to the prevention of dental carries
in order to decrease the need for invasive dental pro-
cedures.
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